Literature DB >> 11986413

Bronchiectasis.

Alan F Barker1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11986413     DOI： 10.1056/NEJMra012519

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  128 in total

1.  Is nitroglycerin effective in treatment of haemoptysis?

Authors:  Yi-pin Zhou; Qi Guo; Xiao-ke Chen; Guo Huang
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

2.  Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

Authors:  Amy E Seitz; Kenneth N Olivier; Jennifer Adjemian; Steven M Holland; D Rebecca Prevots
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

3.  Bronchiectasis exacerbations: The role of atypical bacteria, respiratory syncytial virus and pulmonary function tests.

Authors:  Eugenios I Metaxas; Evangelos Balis; Joseph Papaparaskevas; Nicholas Spanakis; Georgios Tatsis; Athanasios Tsakris
Journal:  Can Respir J       Date:  2015-04-15       Impact factor: 2.409

4.  Blood Neutrophils Are Reprogrammed in Bronchiectasis.

Authors:  Pallavi Bedi; Donald J Davidson; Brian J McHugh; Adriano G Rossi; Adam T Hill
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

5.  Inhaled fluticasone in bronchiectasis: a 12 month study.

Authors:  K W Tsang; K C Tan; P L Ho; G C Ooi; J C Ho; J Mak; G L Tipoe; C Ko; C Yan; W K Lam; M Chan-Yeung
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

6.  Bronchiectasis and non-tuberculous mycobacterial pulmonary infection.

Authors:  W-J Koh; O J Kwon
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

7.  Assessing immune function in adult bronchiectasis.

Authors:  P T King; P Hutchinson; P W Holmes; N J Freezer; V Bennett-Wood; R Robins-Browne; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

8.  Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.

Authors:  Mohammed J Al-Jaghbeer; Julie Ann Justo; William Owens; Joseph Kohn; P Brandon Bookstaver; Jennifer Hucks; Majdi N Al-Hasan
Journal:  Infection       Date:  2018-05-11       Impact factor: 3.553

9.  Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.

Authors:  Hui Xin Ong; Daniela Traini; Giulia Ballerin; Lucy Morgan; Lachlan Buddle; Santo Scalia; Paul M Young
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

10.  Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients.

Authors:  Matthew C Wolfgang; Jeevan Jyot; Andrew L Goodman; Reuben Ramphal; Stephen Lory
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.